1. Home
  2. GHRS vs NTGR Comparison

GHRS vs NTGR Comparison

Compare GHRS & NTGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • NTGR
  • Stock Information
  • Founded
  • GHRS 2018
  • NTGR 1996
  • Country
  • GHRS Ireland
  • NTGR United States
  • Employees
  • GHRS N/A
  • NTGR N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • NTGR Telecommunications Equipment
  • Sector
  • GHRS Health Care
  • NTGR Utilities
  • Exchange
  • GHRS Nasdaq
  • NTGR Nasdaq
  • Market Cap
  • GHRS 849.8M
  • NTGR 803.9M
  • IPO Year
  • GHRS 2021
  • NTGR N/A
  • Fundamental
  • Price
  • GHRS $12.06
  • NTGR $29.07
  • Analyst Decision
  • GHRS Strong Buy
  • NTGR Buy
  • Analyst Count
  • GHRS 8
  • NTGR 1
  • Target Price
  • GHRS $30.63
  • NTGR $29.00
  • AVG Volume (30 Days)
  • GHRS 176.0K
  • NTGR 426.9K
  • Earning Date
  • GHRS 05-08-2025
  • NTGR 07-30-2025
  • Dividend Yield
  • GHRS N/A
  • NTGR N/A
  • EPS Growth
  • GHRS N/A
  • NTGR N/A
  • EPS
  • GHRS N/A
  • NTGR 0.85
  • Revenue
  • GHRS N/A
  • NTGR $671,233,000.00
  • Revenue This Year
  • GHRS N/A
  • NTGR $4.48
  • Revenue Next Year
  • GHRS N/A
  • NTGR $5.04
  • P/E Ratio
  • GHRS N/A
  • NTGR $34.00
  • Revenue Growth
  • GHRS N/A
  • NTGR N/A
  • 52 Week Low
  • GHRS $6.00
  • NTGR $13.96
  • 52 Week High
  • GHRS $20.50
  • NTGR $31.55
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 52.59
  • NTGR 54.66
  • Support Level
  • GHRS $11.50
  • NTGR $27.72
  • Resistance Level
  • GHRS $12.94
  • NTGR $29.22
  • Average True Range (ATR)
  • GHRS 0.98
  • NTGR 0.97
  • MACD
  • GHRS -0.14
  • NTGR -0.04
  • Stochastic Oscillator
  • GHRS 32.73
  • NTGR 53.33

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About NTGR NETGEAR Inc.

Netgear Inc provider of networking technologies for businesses, homes, and service providers. It delivers a wide range of intelligent solutions designed to unleash the full potential of connectivity. The group has two segments: NETGEAR for Business and Connected Home which offers reliable, easy-to-use, high-performance networking solutions, including switches, routers, access points, software, and AV over IP technologies, tailored to meet the diverse needs of organizations of all sizes. The Connected Home segment offers connectivity, powerful performance, and enhanced security features right out of the box, designed to help keep families safe online, and Others. It conduct business across three geographic territories: Americas; Europe, Middle East and Africa; and Asia Pacific.

Share on Social Networks: